Comoros Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.

Press releases published on March 25, 2026

Mar. 25, 2026

Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with AP01 in Patients with Idiopathic Pulmonary Fibrosis

Indeterminate GlobeNewswire

Mar. 25, 2026

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

Indeterminate GlobeNewswire

Mar. 25, 2026

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Mar. 25, 2026

CDT Equity Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

Mar. 25, 2026

2026 Cybersecurity Excellence Awards Winners Announced during RSA Conference as AI Security Dominates

Indeterminate GlobeNewswire

Mar. 25, 2026

Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ET

Indeterminate GlobeNewswire

Mar. 25, 2026

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Indeterminate GlobeNewswire

Mar. 25, 2026

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Indeterminate GlobeNewswire

Mar. 25, 2026

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Mar. 25, 2026

STS Digital Unveils First-to-Market Structured Products Platform, Partnering with Kraken

Indeterminate GlobeNewswire

Mar. 25, 2026

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Indeterminate GlobeNewswire

Mar. 25, 2026

Verano to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Energous Wireless Power Solutions Reports Fiscal Year 2025 Results

Indeterminate GlobeNewswire

Mar. 25, 2026

Notch Raises $30 Million to Bring Production-Ready AI Agents to Regulated Industries

Indeterminate GlobeNewswire

Mar. 25, 2026

Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

Indeterminate GlobeNewswire

Mar. 25, 2026

C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

Indeterminate GlobeNewswire

Mar. 25, 2026

Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval

Indeterminate GlobeNewswire

Mar. 25, 2026

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Indeterminate GlobeNewswire

Mar. 25, 2026

Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Indeterminate GlobeNewswire